Cas No.: 756500-23-9
PRODUCT INFORMATION
Description
Cyclo(RADfK) (Cyclo[Ala-Asp-D-Phe-Lys-Arg]) is a peptide that is commonly used as a negative control in research studies. It is structurally similar to the integrin-binding peptide Cyclo(-RGDfK), but the substitution of Arginine (R) with Alanine (A) in the RGD motif (becoming RAD) abolishes its affinity for integrin receptors, allowing researchers to verify binding specificity.
Molecular Weight
617.70
Purity
> 95%
Formula
C₂₈H₄₃N₉O₇
Product Type
Targeting Peptide
Sequence
Cyclo[Ala-Asp-D-Phe-Lys-Arg]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- FRα-targeting Peptide C7 (CAT#: OLY-1025-YS-13)
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- Pep2 Targeting Peptide (CAT#: OLY-1025-YS-41)
- IRGD Peptide 1 TFA (CAT#: OLY-1025-YS-58)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- CXCL9(74-103) Targeting Peptide (CAT#: OLY-1025-YS-42)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.